Filing Impact
Filing Sentiment
Form Type
144
Annexon, Inc.
Aug 14, 2025
[10-Q] Annexon, Inc. Quarterly Earnings Report
Aug 14, 2025
[SCHEDULE 13G/A] Annexon, Inc. SEC Filing
Aug 6, 2025
[SCHEDULE 13G/A] Annexon, Inc. SEC Filing
Aug 1, 2025
[Form 4] Annexon, Inc. Insider Trading Activity
Jul 16, 2025
[Form 4] Annexon, Inc. Insider Trading Activity
267.70M
101.68M
0.42%
103.17%
9.53%
Biotechnology
Pharmaceutical Preparations
United States
BRISBANE